Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
about
Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic reviewRisk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerHIV: primary and secondary prophylaxis for opportunistic infections.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theNo recurrence of Pneumocystis jirovecii Pneumonia after solid organ transplantation regardless of secondary prophylaxis.Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)Pneumocystis jirovecii pneumonia in kidney transplantation.A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
P2860
Q26829541-DB6D16DB-9AEC-4906-993B-DFFF69B4A0BFQ33584240-10CD246F-7866-4A94-9965-E12C2AA4FE28Q33650105-AE18FB77-F919-4C84-B84D-FE171940E4E0Q33850498-E5E3E5E6-2CB4-4638-A3BE-F5E83431BBF6Q34212799-B7044455-13F9-47ED-ADD5-A271B16D1CB7Q36364216-D7FB29E8-5B8F-4EBD-A254-35C22720A78FQ36948496-00803103-BCAD-48C1-9E3C-47F1195B72B3Q37180338-E89CFAF4-FFE2-406F-BB7D-F4BC03F4B7EBQ37957313-AA65A015-381D-4024-955F-D82646E16E53Q50800026-BD95844F-EA12-4DED-B3C2-4A7B8A1A41AE
P2860
Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@en
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@nl
type
label
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@en
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@nl
prefLabel
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@en
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@nl
P2093
P50
P356
P1476
Discontinuation of secondary p ...... trial by the CIOP Study Group.
@en
P2093
Alessandra Govoni
Andrea Bedini
Changes in Opportunistic Prophylaxis (CIOP) Study Group
Cristina Beltrami
Cristina Mussini
Maria Alessandra Ursitti
Maria Chiara Cerri
Nicola Mongiardo
Patrizio Pezzotti
Roberto Esposito
P304
P356
10.1086/367659
P407
P577
2003-02-12T00:00:00Z